Wetherby Asset Management Inc
- SEC CIK
- 0001279627
- Latest filing
- Nov 14, 2025
DNA holding history
Ginkgo Bioworks Holdings, Inc. in every 13F filed by Wetherby Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNA overviewAll 13F holders of DNAFull Q3 2025 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −14,768−100.0% | Sold out | Holders |
| Q1 2024 | 14,768 | $17.1K | <0.1% | +3,540+31.5% | Added | Holders |
| Q4 2023 | 11,228 | $19.0K | <0.1% | −3,689−24.7% | Reduced | Holders |
| Q3 2023 | 14,917 | $27.0K | <0.1% | +802+5.7% | Added | Holders |
| Q2 2023 | 14,115 | $26.3K | <0.1% | −7,476−34.6% | Reduced | Holders |
| Q1 2023 | 21,591 | $28.7K | <0.1% | −9,080−29.6% | Reduced | Holders |
| Q4 2022 | 30,671 | $51.8K | <0.1% | +30,671 | New | Holders |